Published: 2018-12-08

Articles

PHARMACEUTICAL EXPENDITURE COMPARED ACROSS COUNTRIES

C. van Mosseveld
Abstract 80 | PDF Downloads 40

TOXIC EPIDERMAL NECROLYSIS AND CLARITHROMYCIN

Nadia Khaldi, Alain Miras, Sophie Gromb
Abstract 56 | PDF Downloads 29

COMPLIANCE ASSESSMENT IN DRUG TRIALS: HAS THERE BEEN IMPROVEMENT IN TWO DECADES?

Shiva Jayaraman, Michael J Rieder, Doreen M Matsui
Abstract 57 | PDF Downloads 43

CARDIOVASCULAR COLLAPSE FROM LOW DOSE BUPIVACAINE

Marc E Levsky, Michael A Miller
Abstract 204 | PDF Downloads 93

ARE BRAND-NAME AND GENERIC WARFARIN INTERCHANGEABLE? A SURVEY OF ONTARIO PATIENTS AND PHYSICIANS

Jennifer A Pereira, Anne M Holbrook, Lisa Dolovich Dolovich, Charles Goldsmith, , Lehana Thabane, James D Douketis, Mark Crowther, Shannon M Bates, Jeffrey S Ginsberg
Abstract 81 | PDF Downloads 76

THE ROLE OF BUSPIRONE FOR THE TREATMENT OF CEREBELLAR ATAXIA IN AN OLDER INDIVIDUAL

Jayna M Holroyd-Leduc, Barbara A Liu, Brian E Mak I, Aleksandra Zecevic, Nathan Herrmann, Sandra E Black
Abstract 154 | PDF Downloads 29

CLINICAL TRIAL APPLICATIONS IN CANADA

Agnes V Klein, Anne M Tomalin
Abstract 129 | PDF Downloads 155